The company received complaints regarding the syringes in the kits that revealed dural puncture with some also requiring a blood patch. An inadvertent dural puncture may lead to headache, tinnitus and (rarely) intracranial hemorrhage, according to the safety notice.
IN CASE YOU MISSED IT
- How COVID-19 impacts FDA interactions with medical device manufacturers
- Xeris Pharmaceuticals launches autoinjector for severe hypoglycemia
- Abbott, Tandem seal deal to combine CGM, insulin delivery tech
- Inivata launches lung cancer liquid biopsy test
- Insulet installs thousands of solar panels at global HQ